Restoring Safeguards for Dangerous Abortion Drugs Act

# Summary: Restoring Safeguards for Dangerous Abortion Drugs Act **What the bill would do:** This bill seeks to restrict the use of mifepristone, a medication used in medication abortion procedures. Specifically, it would reinstate stricter federal regulations around how the drug can be distributed and used, reversing recent FDA decisions that relaxed those requirements. The bill would likely require in-person medical visits for obtaining the drug and impose other limitations on its availability compared to current rules. **Who it affects:** The bill would directly impact women seeking medication abortion and the healthcare providers who prescribe it. It would also affect pharmacies and clinics that distribute the drug.

Indirectly, it touches on broader debates about reproductive healthcare access across the country. **Key provisions and current status:** While specific provisions aren't detailed in available summaries, such bills typically include requirements for in-person dispensing, limits on how far into pregnancy the drug can be used, and restrictions on mail distribution. The bill is currently in committee, meaning it has not yet advanced for a full Senate vote. As a Republican-sponsored measure in the divided 119th Congress, its path forward remains uncertain.